0001567619-22-009512.txt : 20220504
0001567619-22-009512.hdr.sgml : 20220504
20220504154357
ACCESSION NUMBER: 0001567619-22-009512
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220429
FILED AS OF DATE: 20220504
DATE AS OF CHANGE: 20220504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Raifeld Pavel
CENTRAL INDEX KEY: 0001813426
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 22891329
MAIL ADDRESS:
STREET 1: 1350 OLD BAYSHORE HIGHWAY, SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Innoviva, Inc.
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1350 OLD BAYSHORE HIGHWAY
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 6502389600
MAIL ADDRESS:
STREET 1: 1350 OLD BAYSHORE HIGHWAY
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: THERAVANCE INC
DATE OF NAME CHANGE: 20020207
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4
1
doc1.xml
FORM 4
X0306
4
2022-04-29
0
0001080014
Innoviva, Inc.
INVA
0001813426
Raifeld Pavel
1350 OLD BAYSHORE HIGHWAY, SUITE 400
BURLINGAME
CA
94010
0
1
0
0
Chief Executive Officer
Common Stock
4533
D
Nonstatutory Stock Option
16.31
2022-05-02
4
A
0
150000
0
A
2023-05-20
2032-05-01
Common Stock
150000
500000
D
Includes (i) 2,500 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 15, 2021 and (ii) 2,033 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on November 15, 2021.
25% of the options will vest on May 20, 2023 and the balance will vest in twelve (12) substantially equal installments thereafter on each three (3) month anniversary of the initial vesting date, in each case, subject to Mr. Raifeld's continuous service through the applicable vesting date, with accelerated vesting in the event of a "change in control" (as defined in the Issuer's 2012 Equity Incentive Plan) or in the event that Mr. Raifeld experiences an "involuntary termination" (as defined in Mr. Raifeld's option agreement) within 24 months following a "change in control."
/s/ Pavel Raifeld
2022-05-04